<!DOCTYPE html>
<!--[if (gt IE 9)|!(IE)]> <!--> <html lang="en" class="no-js has-comments blog-news section-"  itemscope xmlns:og="//opengraphprotocol.org/schema/"> <!--<![endif]-->
<!--[if IE 9]> <html lang="en" class="no-js ie9 lt-ie10 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if IE 8]> <html lang="en" class="no-js ie8 lt-ie10 lt-ie9 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if (lt IE 8)]> <html lang="en" class="no-js lt-ie10 lt-ie9 lt-ie8 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1044.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>
		<meta name="PT" content="Blogs" />
<meta name="PST" content="Blog Post" />
<meta name="sourceApp" content="blogs" />
<meta itemprop="identifier" name="blogpostid" content="100000004320178"><meta name="author" content="Sei Chong" />
<meta name="CLMST" content="Sei Chong" />
<meta name="byl" content="Sei Chong" />
<meta name="GBLC" content="DealBook">
<meta name="PUV" content="normal" />
<meta property="article:published_time" itemprop="datePublished" content="1460370156" />
<meta name="PUD" content="20160411" />
<meta name="pdate" content="20160411" />
<meta name="ptime" content="20160411062236" />
<meta name="utime" content="20160411102236" />
<meta property="article:modified_time" itemprop="dateModified" content="2016-04-11T10:22:36-04:00" />
<meta name="DISPLAYDATE" content="April 11, 2016" />
<meta name="dat" content="April 11, 2016" />
<meta itemprop="articleSection" property="article:section" content="" />
<meta name="CG" content="" />
<meta name="SCG" content="news" />
<meta name="BN" content="news" />
<meta name="robots" content="noodp">
<meta name="des" content="Banking and Financial Institutions;Drugs (Pharmaceuticals);Hedge Funds;Initial Public Offerings;Mergers, Acquisitions and Divestitures;News and News Media;Private Equity;Regulation and Deregulation of Industry">
<meta name="org" content="House of Representatives;Valeant Pharmaceuticals International Inc;Yahoo! Inc">
<meta name="geo" content="Puerto Rico">
<meta property="article:tag" content="Banking and Financial Institutions" />
<meta property="article:tag" content="Drugs (Pharmaceuticals)" />
<meta property="article:tag" content="Hedge Funds" />
<meta property="article:tag" content="Initial Public Offerings" />
<meta property="article:tag" content="Mergers Acquisitions and Divestitures" />
<meta property="article:tag" content="News and News Media" />
<meta property="article:tag" content="Private Equity" />
<meta property="article:tag" content="Regulation and Deregulation of Industry" />
<meta property="article:tag" content="House of Representatives" />
<meta property="article:tag" content="Valeant Pharmaceuticals International Inc" />
<meta property="article:tag" content="Yahoo! Inc" />
<meta property="article:tag" content="Puerto Rico" />
<meta property="article:tag" content="DealBook" />
<meta name="keywords" content="Banking and Financial Institutions,Drugs (Pharmaceuticals),Hedge Funds,Initial Public Offerings,Mergers Acquisitions and Divestitures,News and News Media,Private Equity,Regulation and Deregulation of Industry,House of Representatives,Valeant Pharmaceuticals International Inc,Yahoo! Inc,Puerto Rico,DealBook" />
<link rel="alternate" type="application/json+oembed" href="https://www.nytimes.com/svc/oembed/json/?url=http%3A%2F%2Fnews.blogs.nytimes.com%2F2016%2F04%2F11%2Fmorning-agenda-how-valeants-missteps-derailed-female-viagra%2F" title="Morning Agenda: How Valeant&#8217;s Missteps Derailed Female Viagra" />
<meta name="description" content="Daily Mail in Talks With Private Equity Firms for Yahoo Bid &#124; Puerto Rico Rescue Bill Nearly Complete" />
<meta name="hdl" content="Morning Agenda: How Valeant&#039;s Missteps Derailed Female Viagra" />
<meta property="og:title" content="Morning Agenda: How Valeant&#039;s Missteps Derailed Female Viagra" />
<meta property="og:type" content="article" />
<meta property="og:url" content="//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/" />
<meta property="og:site_name" content="" />
<meta property="og:description" content="Daily Mail in Talks With Private Equity Firms for Yahoo Bid &#124; Puerto Rico Rescue Bill Nearly Complete" />
<meta property="og:image" content="https://static01.nyt.com/images/blogs_v5/../icons/t_logo_2048_black.png"/>
<meta name="thumbnail_150" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta name="twitter:card" value="summary"><meta name="twitter:title" content="Morning Agenda: How Valeant&#039;s Missteps Derailed Female Viagra" />
<meta name="twitter:url" content="//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/" />
<meta name="twitter:description" content="Daily Mail in Talks With Private Equity Firms for Yahoo Bid &#124; Puerto Rico Rescue Bill Nearly Complete" />
<meta name="twitter:image" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta itemprop="thumbnailUrl" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png" name="thumbnail" />
<link rel='prev' title='What We&#8217;re Reading' href='//news.blogs.nytimes.com/2016/04/08/what-were-reading-143/' />
<link rel='next' title='Morning Agenda: $5.1 Billion Fine for Goldman Sachs Less Than Meets the Eye' href='//news.blogs.nytimes.com/2016/04/12/morning-agenda-5-1-billion-fine-for-goldman-sachs-less-than-meets-the-eye/' />
<link rel='canonical' href='//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/' />
<link rel='shortlink' href='//nyti.ms/1Wn2l5Z' />
<link rel='https://github.com/WP-API/WP-API' href='//news.blogs.nytimes.com/json' />
<meta name="adxPage" content="blog.nytimes.com/news/post" />
<link rel="alternate" type="application/rss+xml" title="RSS 2.0" href="//news.blogs.nytimes.com/feed/" />
<meta property="article:collection" content="https://static01.nyt.com/services/json/sectionfronts/index.jsonp" />
<link rel="alternate" href="//mobile.nytimes.com/blogs/news/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/" />
<meta name="dfp-ad-unit-path" content="news" />			<title>Morning Agenda: How Valeant&#039;s Missteps Derailed Female Viagra - The New York Times</title>
            <!--[if (gt IE 9)|!(IE)]> <!-->
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles.css" />
<!--<![endif]-->
<!--[if lte IE 9]>
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-ie.css" />
<![endif]-->
<link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/news.css" />
<link rel="stylesheet" type="text/css" media="print" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-print.css" />
<script>
var NYT = NYT || {}, NYTD = NYTD || {};
</script>
                        	<script src="https://int.nyt.com/assets/blogs/latest/js/blogs/layout.js"></script>
	<script type="text/javascript">var googletag=googletag||{};googletag.cmd=googletag.cmd||[],function(){var t=document.createElement("script");t.async=!0,t.type="text/javascript";var e="https:"==document.location.protocol;t.src=(e?"https:":"http:")+"//www.googletagservices.com/tag/js/gpt.js";var o=document.getElementsByTagName("script")[0];if (!/NYT-T=out/.test(document.cookie)) {o.parentNode.insertBefore(t,o)}}();</script>
<script id="magnum-feature-flags" type="application/json">["limitFabrikSave","facebookOauthButton","videoVHSCover","videoVHSShareTools","videoVHSEmbeddedOnly","removeInternationalEdition","piiBlockDFP","indexAsHeaderBidder","caslOpt"]</script>
<script>
var require = {
    baseUrl: 'https://int.nyt.com/assets/',
    waitSeconds: 20,
    paths: {
        'foundation': 'blogs/latest/js/foundation',
        'shared': 'blogs/latest/js/shared',
        'blogs': 'blogs/latest/js/blogs',
        'auth/mtr': 'https://static01.nyt.com/js/mtr',
        'auth/growl': 'https://static01.nyt.com/js/auth/growl/default',
        'vhs': 'https://static01.nyt.com/video/vhs/build/vhs-2.x.min'
    }
};
</script>
<!--[if (gte IE 9)|!(IE)]> <!-->
<script data-main="foundation/main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script>
require.map = { '*': { 'foundation/main': 'foundation/legacy_main' } };
</script>
<script data-main="foundation/legacy_main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<![endif]-->
<script>
require(['foundation/main'], function () {
    require(['auth/mtr']);
});
</script>
<!--esi
<script id="user-info-data" type="application/json">
<esi:include src="/svc/web-products/userinfo-v3.json" />
</script>
-->
    	</head><body class="single single-post postid-4568 blog-universal nyt-blog-news full-width-headline" id="" data-env="production" data-region="ewr1">
	<div id="shell" class="shell">
			<header id="masthead" class="masthead masthead-theme-standard" role="banner">
    <div class="container">
        <div class="quick-navigation button-group">
            <button class="button sections-button"><i class="icon sprite-icon"></i><span class="button-text">Sections</span></button>
            <button class="button home-button" data-href="https://www.nytimes.com/" title="Go to the home page to see the latest top stories."><i class="icon sprite-icon"></i>
                <span class="button-text">Home</span>
            </button>
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <a class="button skip-button skip-to-content visually-hidden focusable" href="#main">Skip to content</a>
                                </div><!-- close button-group -->
        <div class="branding">
            <h2 class="branding-heading">
                <a id="branding-heading-link" href="https://www.nytimes.com/">
                    <span class="visually-hidden">The New York Times</span>
                </a>
            </h2>
            <script>window.magnum.writeLogo('small', 'https://int.nyt.com/assets/blogs/latest/images/foundation/logos/', '', 'masthead-theme-standard', 'standard', 'branding-heading-link', 'blogs');</script>
        </div><!-- close branding -->
        <div class="story-meta">
    <h6 class="kicker">
        <span class="kicker-label">
			            <a href="//news.blogs.nytimes.com">
                News            </a>
			        </span>

                <span class="pipe">|</span>
        Morning Agenda: How Valeant&#8217;s Missteps Derailed Female Viagra        
    </h6>
</div><!-- close story-meta -->


        <div class="user-tools">
            <div id="Bar1" class="ad bar1-ad nocontent robots-nocontent"></div>
            <div id="sharetools-masthead" class="sharetools theme-classic"
	 data-shares="email,facebook,twitter,show-all|More"
	 data-url="//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/"
	 data-title="Morning Agenda: How Valeant&#8217;s Missteps Derailed Female Viagra"
	 data-description="&lt;span class=&quot;excerpt-inner&quot;&gt;Daily Mail in Talks With Private Equity Firms for Yahoo Bid | Puerto Rico Rescue Bill Nearly Complete&lt;/span&gt;&lt;a href=&quot;//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
	data-publish-date="April 11, 2016 6:22 am">
<div class="ad sharetools-inline-article-ad hidden"></div>
</div><!-- close shareTools -->
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <div class="user-tools-button-group button-group">
                <button class="button subscribe-button hidden" data-href="https://www.nytimes.com/subscriptions/Multiproduct/lp3004.html?campaignId=4XUYF">Subscribe Now</button>
                <button class="button login-button login-modal-trigger hidden">Log In</button>
                <button class="button comments-button  button-masthead" data-skip-to-para-id="">
</button>
                                <button class="button notifications-button hidden"><i class="icon sprite-icon"></i><span class="button-text">0</span></button>
                <button class="button user-settings-button"><i class="icon sprite-icon"></i><span class="button-text">Settings</span></button>
            </div><!-- close user-tools-button-group -->
        </div><!-- close user-tools -->
    </div><!-- close container -->
    <div class="search-flyout-panel flyout-panel">
    <button class="button close-button" type="button"><i class="icon"></i><span class="visually-hidden">Close search</span></button>
    <nav class="search-form-control form-control layout-horizontal">
    <h2 class="visually-hidden">Site Search Navigation</h2>
    <form class="search-form" role="search">
        <div class="control">
            <div class="label-container visually-hidden">
                                <label for="search-input">Search NYTimes.com</label>
                            </div>
            <div class="field-container">
                                <input id="search-input" name="search-input" type="text" class="search-input text" autocomplete="off" placeholder="Search NYTimes.com" />
                
                <button type="button" class="button clear-button" tabindex="-1" aria-describedby="clear-search-input"><i class="icon"></i><span id="clear-search-input" class="visually-hidden">Clear this text input</span></button>
                <div class="auto-suggest" style="display: none;">
                    <ol></ol>
                </div>
                <button class="button submit-button" type="submit">Go</button>
            </div>
        </div><!-- close control -->
    </form>
</nav>


</div><!-- close flyout-panel -->
    <div id="notification-modals" class="notification-modals"></div>
</header>
					<nav id="ribbon" class="ribbon ribbon-start nocontent robots-nocontent" aria-hidden="true">
    <div class="nocontent robots-nocontent">
        <ol class="ribbon-menu">
            <li class="collection ribbon-loader">
                <div class="loader "><span class="visually-hidden">Loading...</span></div>
            </li>
        </ol>
        <div class="ribbon-navigation-container">
            <nav class="ribbon-navigation next">
                <span class="visually-hidden">See next articles</span>
                <div class="arrow arrow-right">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
            <nav class="ribbon-navigation previous">
                <span class="visually-hidden">See previous articles</span>
                <div class="arrow arrow-left">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
        </div>
    </div><!-- close nocontent -->
</nav>
						<nav id="navigation" class="navigation">
    <h2 class="visually-hidden">Site Navigation</h2>
</nav><!-- close navigation -->

<nav id="mobile-navigation" class="mobile-navigation hidden">
    <h2 class="visually-hidden">Site Mobile Navigation</h2>
</nav><!-- close mobile-navigation -->

    <div id="navigation-edge" class="navigation-edge"></div>
				<main id="main" class="main" role="main">
				<div id="TopAd" class="ad top-ad"></div>
				<div id="mobilebanner" class="ad mobilebanner"></div>
								<div id="story" class="story theme-main">
		<div id="news" class="spanAC blog">
				<div class="postHeader story-header">
	<div class="story-meta">
						<h1 class="entry-title story-heading">Morning Agenda: How Valeant&#8217;s Missteps Derailed Female Viagra</h1>
		<div class="story-meta-footer">
			<address class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
				By Sei Chong			</address>
			<!-- date published --><time class="dateline " datetime="2016-04-11T10:22:36+00:00" itemprop="datePublished">April 11, 2016</time>
			<!-- date updated --><span class="visually-hidden updated">April 11, 2016</span>			<div class="inside-story"></div><!-- Although this is empty, it is required for layout parity with NYT5 -->
		</div>
	</div>
</div>
<div class="a-column" id="a-col">
	<div id="content" class="hfeed">
			<article class="post-4568 post type-post status-publish hentry category-dealbook tag-banking-and-financial-institutions tag-drugs-pharmaceuticals tag-hedge-funds tag-house-of-representatives tag-initial-public-offerings tag-mergers-acquisitions-and-divestitures tag-news-and-news-media tag-private-equity tag-puerto-rico tag-regulation-and-deregulation-of-industry tag-valeant-pharmaceuticals-international-inc tag-yahoo-inc des-banking-and-financial-institutions des-drugs-pharmaceuticals des-hedge-funds des-initial-public-offerings des-mergers-acquisitions-and-divestitures des-news-and-news-media des-private-equity des-regulation-and-deregulation-of-industry org-house-of-representatives org-valeant-pharmaceuticals-international-inc org-yahoo-inc geo-puerto-rico" id="post-4568">
                        <div class="visually-hidden">
                <span itemprop="headline" class="entry-title">Morning Agenda: How Valeant&#8217;s Missteps Derailed Female Viagra</span>
                <span class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
                    By Sei Chong                </span>
                <!-- date published --><time class="dateline " datetime="2016-04-11T10:22:36+00:00" itemprop="datePublished">April 11, 2016 6:22 am</time>
			<!-- date updated --><span class="visually-hidden updated">April 11, 2016 6:22 am</span>            </div>
			<div class="entry-content">
			<div id="sharetools-story" class="sharetools theme-classic sharetools-story" data-shares="email|Email,facebook|Share,twitter|Tweet,save|Save,show-all|More,ad" data-url="//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/" data-title="Morning Agenda: How Valeant&#8217;s Missteps Derailed Female Viagra" data-description="Daily Mail in Talks With Private Equity Firms for Yahoo Bid | Puerto Rico Rescue Bill Nearly Complete">
				<div class="ad sharetools-inline-article-ad"></div>
				<div id="MiddleLeft" class="ad middle-left-ad nocontent robots-nocontent"></div>
				</div><div class="round-up">
<div class="ru-top-story">
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>HOW VALEANTâS MISSTEPS DERAILED FEMALE VIAGRA</strong> <span class="divider"> | </span></span> In August, Sprout Phamaceuticals was flying high: It had finally received regulatory approval for its drug Addyi to treat low sex drive in women, and a day after the Food and Drug Administration approved the drug, Valeant Pharmaceuticals International bought Sprout for $1 billion, twice its value only two months earlier. But a series of missteps after the deal, combined with problems at Valeant that have depressed its stock by 85 percent, <b> derailed what was once hailed as the âfemale Viagra,â</b> <a href="//www.nytimes.com/2016/04/10/business/female-viagra-addyi-valeant-dysfunction.html"> Katie Thomas and Gretchen Morgenson write in The New York Times</a>. </p>
<p class="story-body-text" itemprop="articleBody">Last week, Valeant dismissed the entire sales force behind the drug and said it planned to reintroduce Addyi this year. Doctors had prescribed the drug fewer than 4,000 times as of February. Valeantâs purchase of Sprout turned out to be <b> âa colossal failure,â</b> said Vicki Bryan, an analyst at Gimme Credit, a debt analysis firm. âTo have it fall apart in a couple of months? Thatâs very alarming.â </p>
<p class="story-body-text" itemprop="articleBody">The drug had its critics, who <b> questioned its effectiveness and pointed out its potential side effects</b>, like dangerous drops in blood pressure or fainting. Still, some analysts predicted that millions of women would take the drug, and Sprout built a huge force in anticipation of those sales before F.D.A. approval. </p>
<p class="story-body-text" itemprop="articleBody">Soon after Valeant took over, it doubled Addyiâs price to $800 and planned to sell it to patients through a mail-order pharmacy, Philidor Rx Services. But Valeant then announced it was severing ties with Philidor, <b> leaving the drug without a distributor</b>. The companyâs relationship with the pharmacy is now under federal investigation, as are its drug-pricing policies. Former Sprout employees told Ms. Thomas and Ms. Morgenson that a <b> change in marketing strategy</b> made it difficult for them to sell doctors on the pill and that they <b> didnât have access to many of their standard sales tools</b>, like basic promotional materials. Valeant also halted a planned speakersâ program, in which doctors explained the drug to their colleagues. </p>
<p class="story-body-text" itemprop="articleBody">âAs weeks passed, several members of the sales team began to suspect that <b> Valeant was either not interested or incapable of effectively selling Addyi</b>, according to the former employees,â Ms. Thomas and Ms. Morgenson write. Near the end of 2015, Cindy Whitehead, Sproutâs chief executive, left the company, and so did sales representatives, who were not replaced. </p>
<p class="story-body-text" itemprop="articleBody">Dr. James A. Simon, a member of Valeantâs scientific advisory board for Addyi, said <b> Valeant seemed out of its depth</b>. âThey didnât home-grow things at Valeant,â said Dr. Simon, who served as the chief medical officer at Sprout from 2012 to 2013. âThis is a product that needed to be homegrown.â<br />
</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>DAILY MAIL IN TALKS WITH PRIVATE EQUITY FIRMS FOR YAHOO BID</strong> <span class="divider"> | </span></span> Daily Mail and General Trust, the parent company of the British tabloid The Daily Mail, said on Monday that it is holding discussions with private equity firms for a possible bid for Yahooâs assets, <a href="https://next.ft.com/content/78c73d9c-ffb3-11e5-9cc4-27926f2b110c"> The Financial Times reports</a>. âGiven the success of DailyMail.com and Elite Daily, we have been in discussions with a number of parties who are potential bidders,â Daily Mail and General Trust said. The company declined to name any potential partners, but <a href="//www.wsj.com/articles/u-k-s-daily-mail-explores-bid-for-yahoo-backed-by-private-equity-1460324999"> The Wall Street Journal reports</a> that <b> one of the private equity firms is General Atlantic</b>, citing people familiar with the matter. </p>
<p class="story-body-text" itemprop="articleBody"> The Wall Street Journal, which first reported news of the Daily Mailâs interest, also reports that a bid by Daily Mail and General Trust could take one of two forms. The first would have <b> a private equity firm bid for all of Yahooâs United States operations</b> and have the <b> Mail take over the news and media businesses</b> like Yahoo Finance and Yahoo News. The other alternative would have the <b> private equity firm acquire Yahoo and put all of its media and news units into a new company</b> that would include the Mailâs digital businesses, DailyMail.com and Elite Daily. The <b> Mail would run the media company</b> and receive a larger equity stake than under the first scenario. </p>
<p class="story-body-text" itemprop="articleBody"> Companies have until April 18 to submit bids. So far, <b>Verizon Communications, IAC/InterActiveCorp and CBS have met with Yahoo</b>, The Wall Street Journal reports. Analysts and executives following the sale process told the newspaper that <b> Verizon is seen as a front-runner</b>.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>ON THE AGENDA</strong> <span class="divider"> | </span></span> <b> William C. Dudley</b>, president of the Federal Reserve Bank of New York, speaks at the Association for Neighborhood and Housing Development conference at 9:25 a.m. <b> Robert S. Kaplan</b>, the president of the Federal Reserve Bank of Dallas, participates in a discussion in Ruston, La., at 1 p.m. <b> Treasury Secretary Jacob J. Lew</b> speaks to the Council on Foreign Relations on âAmerica and the Global Economy: The Case for U.S. Leadershipâ at 8:30 a.m. The aluminum giant <b> Alcoa</b> holds its quarterly earnings conference call at 5 p.m.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>PUERTO RICO RESCUE BILL NEARLY COMPLETE</strong> <span class="divider"> | </span></span> House Natural Resources Committee staff members were said to be close on Friday to completing a revised bill that would allow Puerto Rico to wipe out debt under close federal supervision, <a href="//www.nytimes.com/2016/04/09/business/dealbook/puerto-rico-rescue-bill-nears-completion-in-house-committee.html"> Mary Williams Walsh reports in DealBook</a>. The package would put Puerto Ricoâs financial affairs under <b> the supervision of a federal oversight board</b> and allow the island to shed debt in a <b> bankruptcylike federal court proceeding</b> after meeting certain requirements. </p>
<p class="story-body-text" itemprop="articleBody"> The bill has a number of measures opposed by creditors, and legislative aides said that further refinements are likely. The committee is scheduled to <b> take testimony on the rescue package on Wednesday</b>, and aides said they hoped to <b> send a finished bill to the House on Thursday</b>.</p>
<p class="story-body-text" itemprop="articleBody"> One of the more contentious provisions in the bill is the so-called cramdown, which allows a court to force creditors to accept less money for their claims than they want. Puerto Ricoâs creditors say allowing cramdowns will <b> skew any debt restructuring in the islandâs favor</b> before negotiations. Lawmakers are considering whether to <b> require Puerto Rico to work out all settlements</b> before entering the court-supervised phase of its restructuring. Another contentious provision that is still being resolved is <b> whether to halt creditor lawsuits while Puerto Rico is under federal oversight</b>. As of Friday, the lawmakers were considering whether these concerns might be allayed by <b> halting all lawsuits for a short period</b> â perhaps just six months, for example.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong></strong> <span class="divider"> | </span></span> <em>Contact <a href="mailto:sei.chong@nytimes.com">sei.chong@nytimes.com</a></em></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//dealbook.blogs.nytimes.com/category/mergers-acquisitions/">Mergers &#038; Acquisitions &#187;</a></h6>
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="Small, Piecemeal Mergers in Health Care Fly Under Regulatorsâ Radars" src="https://static01.nyt.com/images/2016/04/08/business/09mergers1/09mergers1-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Small, Piecemeal Mergers in Health Care Fly Under Regulatorsâ Radars</strong> <span class="divider"> | </span></span> As âcreeping consolidationâ deals add up â a hospital here, a doctorâs office there â they raise questions on where antitrust officials should focus their attention.<br /><span class="kicker"><a href="//www.nytimes.com/2016/04/09/business/small-piecemeal-mergers-in-health-care-fly-under-regulators-radars.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>U.S. Investor Group Close to Buying Swansea Soccer Club</strong> <span class="divider"> | </span></span> Jason Levien, part owner of Major League Soccerâs D.C. United, and Steve Kaplan, one of Oaktree Capital Managementâs founders, lead a group that is close to taking a controlling interest in Swansea City, Bloomberg reports.<br /><span class="kicker"><a href="//www.bloomberg.com/news/articles/2016-04-09/swansea-soccer-club-nears-sale-to-kaplan-levien-investor-group"> BLOOMBERG NEWS</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="HNA Group of China Offers to Buy Gategroup for $1.5 Billion" src="https://static01.nyt.com/images/2016/04/12/business/12db-gategroup_web1/12db-gategroup_web1-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>HNA Group of China Offers to Buy Gategroup for $1.5 Billion</strong> <span class="divider"> | </span></span> The deal would expand the presence of HNA, the owner of Hainan Airlines, in the global aviation services industry.<br /><span class="kicker"><a href="//www.nytimes.com/2016/04/12/business/dealbook/hna-group-of-china-offers-to-buy-gategroup-for-1-5-billion.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>CaixaBank Agrees to Deal for Portuguese Bank Stake</strong> <span class="divider"> | </span></span> The Spanish lender CaixaBank has reached a last-minute agreement with the Angolan investor Isabel dos Santos that is expected to see the bank buy her stake in Banco BPI, Portugalâs fourth-largest lender, The Financial Times reports.<br />
<br /><span class="kicker"><a href="https://next.ft.com/content/1b32a6fa-ff7a-11e5-99cb-83242733f755"> THE FINANCIAL TIMES </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Standard Chartered Said to Plan Sale of $4.4 Billion in Asian Assets</strong> <span class="divider"> | </span></span> Standard Chartered is seeking to sell at least $4.4 billion of assets in Asia, Bloomberg reports, citing people with knowledge of the matter.<br /><span class="kicker"><a href="//www.bloomberg.com/news/articles/2016-04-11/standard-chartered-said-to-start-4-4-billion-asian-asset-sale"> BLOOMBERG NEWS </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Bond Investors Nervous About U.S. Merger Sentiment</strong> <span class="divider"> | </span></span> As the United States increasingly reins in big mergers, bond investors are on edge over the possibility that competition for corporate bonds could intensify if government rules scuttle other large deals, The Financial Times reports .<br /><span class="kicker"><a href="https://next.ft.com/content/40ab0a22-fdf8-11e5-a31a-7930bacb3f5f"> THE FINANCIAL TIMES </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/b/banks_and_banking/index.html">INVESTMENT BANKING &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Wall Street Retools Incentives for Millennials</strong> <span class="divider"> | </span></span> JPMorgan Chase, Citigroup and other investment banks have revamped their rules and have added sweeteners for young employees, tweaking the delayed-gratification model to better suit the expectations of millennials, The Wall Street Journal reports. <br /><span class="kicker"><a href="//www.wsj.com/articles/millennial-employees-confound-big-banks-1460126369"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Why Millennials Quit</strong> <span class="divider"> | </span></span> Millennials who work at prominent management consulting firms or big banks are up against the widest gap between expectations and reality that the professional world has ever seen â and itâs not their fault, writes Lucy Kellaway of The Financial Times.  <br /><span class="kicker"><a href="https://next.ft.com/content/0c7ed03a-fbeb-11e5-8f41-df5bda8beb40">THE FINANCIAL TIMES</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Caspersen Accused of Taking $14 Million From Friends and Family</strong> <span class="divider"> | </span></span> Andrew Caspersen, the banker charged with fraud, was accused by his former employer, PJT Partners, of taking $14 million from his family and friends, Bloomberg reports. <br /><span class="kicker"><a href="//www.bloomberg.com/news/articles/2016-04-08/caspersen-duped-family-friends-for-14-million-pjt-alleges"> BLOOMBERG NEWS </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Wells Fargo Admits to Deception as Part of $1.2 Billion Settlement</strong> <span class="divider"> | </span></span> Wells Fargo admitted to deceiving the government into insuring thousands of risky mortgages as it formally reached a $1.2 billion settlement with the Justice Department, Reuters reports. <br /><span class="kicker"><a href="//www.reuters.com/article/us-wellsfargo-settlement-idUSKCN0X52HK"> REUTERS</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/i/initial_public_offerings/index.html">I.P.O./OFFERINGS &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>J. Jill Said to Hire Banks for Possible I.P.O.</strong> <span class="divider"> | </span></span> The J. Jill Group has hired Bank of America, Morgan Stanley and Jefferies Group as underwriters for a possible initial public offering, less than a year after it was bought by the private equity firm TowerBrook Capital Partners, The Wall Street Journal reports, citing people familiar with the matter. <br /><span class="kicker"><a href="//www.wsj.com/articles/clothing-retailer-j-jill-group-takes-steps-for-possible-ipo-1460140166"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>MGM Growth Properties to Start Marketing I.P.O. </strong> <span class="divider"> | </span></span> MGM Growth Properties, a real estate investment trust, will start marketing its initial public offering to investors on Monday in a road show that aims to raise as much as $1.2 billion, Reuters reports, citing unidentified sources.<br />
<br /><span class="kicker"><a href="//www.reuters.com/article/us-mgmgrowthproperties-ipo-idUSKCN0X52A2"> REUTERS </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/c/credit_crisis/financial_regulatory_reform/index.html">LEGAL/REGULATORY &#187;</a></h6>
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="Big Board Aims to Keep an Upstart at Bay, but Copy Its Technology" src="https://static01.nyt.com/images/2015/12/19/business/20gret-web1/20gret-web1-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Big Board Aims to Keep an Upstart at Bay, but Copy Its Technology</strong> <span class="divider"> | </span></span> While the Investors Exchange awaits official status from the S.E.C., the New York Stock Exchange wants to adopt its would-be rivalâs trading innovation, Gretchen Morgenson writes in the Fair Game column.<br /><span class="kicker"><a href="//www.nytimes.com/2016/04/10/business/big-board-wants-to-copy-a-rivals-platform-but-keep-the-rival-at-bay.html">Fair Game &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Senate Panel Threatens to Hold Valeant C.E.O. in Contempt</strong> <span class="divider"> | </span></span> A Senate committee said that it may start contempt proceedings against J. Michael Pearson, chief executive officer of Valeant Pharmaceuticals International, for failing to appear to give testimony related to an investigation on drug pricing, Bloomberg reports.<br />
<br /><span class="kicker"><a href="//www.bloomberg.com/news/articles/2016-04-09/valeant-ceo-pearson-may-be-held-in-contempt-by-senate-committee"> BLOOMBERG NEWS </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Ex-Treasury Official Joins Rokos Capital</strong> <span class="divider"> | </span></span> Seth Carpenter, a senior former Treasury official, has joined Rokos Capital Management, The Financial Times reports. <br /><span class="kicker"><a href="https://next.ft.com/content/f16c0df2-969b-3758-ada1-b660b4be30f8"> THE FINANCIAL TIMES </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Bangladesh Theft Investigation Looking at After-Hours Procedures</strong> <span class="divider"> | </span></span> The hackers who stole $101 million out of Bangladeshâs central bank account at the Federal Reserve Bank of New York may have benefited from a more pedestrian source: bankersâ hours, The Wall Street Journal reports. <br /><span class="kicker"><a href="//www.wsj.com/articles/the-accidental-accomplice-in-central-bank-cyberheist-bankers-hours-1460194204"> THE WALL STREET JOURNAL<br />
 </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="Olympus Investigation Shows Ethical Lapses and a Caterer With Clout" src="https://static01.nyt.com/images/2016/04/10/business/10OLYMPUS1/10OLYMPUS1-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Olympus Investigation Shows Ethical Lapses and a Caterer With Clout</strong> <span class="divider"> | </span></span> Two years after admitting to accounting fraud, the camera maker Olympus hired its cafeteria operator to handle a dispute with Chinese customs authorities. Soon after, the case was inexplicably dropped.<br /><span class="kicker"><a href="//www.nytimes.com/2016/04/10/business/international/olympus-investigation-shows-ethical-lapses-and-a-caterer-with-clout.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="newsletter-signup">
<p class="story-body-text" itemprop="articleBody"><a href="//dealbook.nytimes.com/dealbook-e-mail/">Sign up for the DealBook Newsletter</a>, delivered every morning and afternoon.</p>
</div>
<p class="story-body-text" itemprop="articleBody"></p>
</div>
			<footer class="entry-footer">
				
				<div id="sharetools-post-footer" class="sharetools theme-classic"
					data-shares="show-all|Share"
					data-url="//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/"
					data-title="Morning Agenda: How Valeant&#8217;s Missteps Derailed Female Viagra"
					data-description="&lt;span class=&quot;excerpt-inner&quot;&gt;Daily Mail in Talks With Private Equity Firms for Yahoo Bid | Puerto Rico Rescue Bill Nearly Complete&lt;/span&gt;&lt;a href=&quot;//news.blogs.nytimes.com/2016/04/11/morning-agenda-how-valeants-missteps-derailed-female-viagra/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
					>
					<div class="ad sharetools-inline-article-ad hidden"></div>
				</div>
				<div class="footer-tags">
									</div>
			</footer>
		</article>
		<section id="whats-next" class="whats-next nocontent robots-nocontent">
    <h2 class="visually-hidden">What's Next</h2>
    <div class="nocontent robots-nocontent">
        <div class="loader-container">
            <div class="loader loader-t-logo-32x32-ecedeb-ffffff"><span class="visually-hidden">Loading...</span></div>
        </div>
    </div><!-- close nocontent -->
</section>

		</div> <!-- end content -->
</div><!-- end .a-column -->
<div class="cColumn nocontent robots-nocontent">
	<aside>
			<div class="module ad" id="MiddleRight"></div>
        	</aside>
</div>		<div class="clear"></div>
	</div><!-- end blog wrap -->
	<div class="hideContent"></div>

	
<!-- Google Analytics start -->
<script type="text/javascript">
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;if (!/NYT-T=out/.test(document.cookie)) {m.parentNode.insertBefore(a,m)} })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-4406282-154',  { 'alwaysSendReferrer': true } );
ga('send', 'pageview');
</script>
<!-- Google Analytics end -->
		<div id="mobilebanner2" class="ad mobilebanner2"></div>
		<div class="accessibility-ad-header visually-hidden">
    <p>Advertisement</p>
</div>
<div id="SponLink" class="text-ad bottom-left-ad nocontent robots-nocontent"></div>

		<div id="Top5" class="ad top5-ad hidden nocontent robots-nocontent"></div>

					</div>
			<div class="search-overlay"></div>
		</main><!-- close main -->
						<footer id="page-footer" class="page-footer" role="contentinfo">
    <nav>
         <ul>
             <li>
                <a href="https://www.nytco.com" itemprop="copyrightNotice">
                    &copy; <span itemprop="copyrightYear">2017</span>
					<span itemprop="copyrightHolder provider sourceOrganization" itemscope
						itemtype="//schema.org/Organization"
						itemid="//www.nytimes.com">
						<span itemprop="name"> The New York Times Company</span>
						<meta itemprop="tickerSymbol" content="NYSE NYT"/>
					</span>
                </a>
            </li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/infoservdirectory.html">Contact Us</a></li>
            <li><a href="//www.nytco.com/careers/">Work With Us</a></li>
            <li><a href="//nytmediakit.com/">Advertise</a></li>
            <li><a href="https://www.nytimes.com/content/help/rights/privacy/policy/privacy-policy.html#pp">Your Ad Choices</a></li>
            <li><a href="https://www.nytimes.com/privacy">Privacy</a></li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/agree.html" itemprop="usageTerms">Terms of Service</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/content/help/rights/sale/terms-of-sale.html">Terms of Sale</a></li>
         </ul>
    </nav>
    <nav class="last-nav">
        <ul>
            <li><a href="//spiderbites.nytimes.com">Site Map</a></li>
            <li><a href="https://www.nytimes.com/membercenter/sitehelp.html">Help</a></li>
            <li><a href="https://myaccount.nytimes.com/membercenter/feedback.html">Site Feedback</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/subscriptions/Multiproduct/lp5558.html?campaignId=37WXW">Subscriptions</a></li>
        </ul>
    </nav>
</footer>		</div><!-- close shell -->
	<script>
require(['foundation/main'], function () {
    require(['blogs/main']);
    require(['jquery/nyt', 'foundation/views/page-manager'], function ($, pageManager) {
        if (window.location.search.indexOf('disable_tagx') > 0) {
            return;
        }
        $(document).ready(function () {
            require(['https://a1.nyt.com/analytics/json-kidd.min.js'], function () {
                pageManager.trackingFireEventQueue();
            });
        });
    });
});
</script>

	<div id="Inv1" class="ad inv1-ad hidden"></div>
<div id="Inv2" class="ad inv2-ad hidden"></div>
<div id="Inv3" class="ad inv3-ad hidden"></div>
<div id="ab1" class="ad ab1-ad hidden"></div>
<div id="ab2" class="ad ab2-ad hidden"></div>
<div id="ab3" class="ad ab3-ad hidden"></div>
<div id="prop1" class="ad prop1-ad hidden"></div>
<div id="prop2" class="ad prop2-ad hidden"></div>
<div id="Anchor" class="ad anchor-ad hidden"></div>
<div id="ADX_CLIENTSIDE" class="ad adx-clientside-ad hidden"></div>
		<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"b5bcf2eba4","applicationID":"5164608","transactionName":"YwFXZhRYVhAEVUZcX1pLYEAPFlkTFRtQWV9TFxtCDkk=","queueTime":0,"applicationTime":49,"ttGuid":"","agentToken":"","userAttributes":"","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
